
Keywords: ALT; alternative lengthening of telomeres; BP; base pair; CLL; chronic lymphatic leukemia; CSS; cancer specific survival; CI; Confidence interval; DFS; disease free survival; EFS; event free survival; FISH; fluorescent in situ hybridization; GEP-NET; gast